UNCLASSIFIED//
ROUTINE
R 152239Z NOV 21 MID600051180185U
FM CNO WASHINGTON DC
TO NAVADMIN
INFO CNO WASHINGTON DC
BT
UNCLAS
NAVADMIN 256/21
PASS TO OFFICE CODES:
FM CNO WASHINGTON DC//N1//
INFO CNO WASHINGTON DC//N1//
MSGID/GENADMIN/CNO WASHINGTON DC/CNO/NOV//
SUBJ/CCDA GUIDANCE TO COMMANDERS//
REF/A/DOC/SD/24AUG21//
REF/B/MSG/SECNAV/302126ZAUG21//
REF/C/MSG/OPNAV/311913ZAUG21//
REF/D/MSG/OPNAV/132050ZOCT21//
REF/E/DOC/BUMED/7OCT13//
REF/F/DOC/BUPERS/16MAR20//
REF/G/DOC/OPNAV/15AUG20//
REF/H/DOC/BUMED/03SEP21//
REF/I/DOC/OPNAV/10NOV09//
REF/J/MSG/OPNAV/011621ZNOV21//
REF/K/DOC/OPNAV/02SEP09//
REF/L/DOC/OPNAV/30OCT19//
REF/M/DOC/OPNAV/09OCT19//
REF/N/DOC/OPNAV/01OCT18//
REF/O/DOC/BUPERS/07MAY20//
REF/P/DOC/OPNAV/09OCT19//
REF/Q/DOC/OPNAV/29MAY07//
REF/R/DOC/OPNAV/07DEC06//
REF/S/DOC/OPNAV/25OCT21//
REF/T/DOC/OPNAV/05OCT17//
REF/U/DOC/OPNAV/01APR19//
REF/V/DOC/OPNAV/17JAN20//
REF/W/DOC/OPNAV/11APR21//
REF/X/DOC/SECNAV/30OCT18//
REF/Y/DOC/BUPERS/19SEP18//
REF/Z/DOC/SECNAV/28MAR19//
REF/AA/DOC/SECNAV/15APR19//
NARR/REF A IS THE SECRETARY OF DEFENSE MEMO MANDATING CORONAVIRUS DISEASE
2019 VACCINATION FOR DEPARTMENT OF DEFENSE SERVICE MEMBERS.
REF B IS ALNAV 062/21, 2021-2022 DEPARTMENT OF THE NAVY MANDATORY COVID-19
VACCINATION POLICY.
REF C IS NAVADMIN 190/21, 2021-2022 NAVY MANDATORY COVID-19 VACCINATION AND
REPORTING POLICY.
REF D IS NAVADMIN 225/21, COVID-19 CONSOLIDATED DISPOSITION AUTHORITY (CCDA).
REF E IS BUMEDINST 6230.15B, IMMUNIZATIONS AND CHEMOPROPHYLAXIS FOR THE
PREVENTION OF INFECTIOUS DISEASE.
REF F IS BUPERSINST 1730.11A, STANDARDS AND PROCEDURES GOVERNING THE
ACCOMMODATION OF RELIGIOUS PRACTICES.
REF G IS MILPERSMAN 1730-020, IMMUNIZATION EXEMPTIONS FOR RELIGIOUS BELIEFS.
REF H IS BUMEDNOTE 6300, NAVY CORONAVIRUS DISEASE 2019 VACCINE MEDICAL
TEMPORARY, AND MEDICAL PERMANENT EXEMPTION FOR MEDICAL CONTRAINDICATION
APPROVAL PROCESS.
REF I IS MILPERSMAN 1910-154, SEPARATION BY REASON OF ENTRY LEVEL PERFORMANCE
AND CONDUCT.
REF J IS MILPERSMAN 1910-600, FORWARDING CASES TO THE SEPARATION AUTHORITY
(SA).
REF K IS NAVADMIN 249/21, CCDA REPORTING REQUIREMENTS.
REF L IS MILPERSMAN 1611-010, OFFICER PERFORMANCE AND SEPARATIONS FOR CAUSE.
REF M IS MILPERSMAN 1616-040, ENLISTED PERFORMANCE (E-6/7/8/9).
REF N IS MILPERSMAN 1610-015, DOCUMENTATION ON FITNESS REPORTS AND
PERFORMANCE EVALUATIONS FOR FAILURE TO MAINTAIN DEPLOYABILITY OR INDIVIDUAL
MEDICAL READINESS.
REF O IS BUPERSINST 1610.10E, NAVY PERFORMANCE EVALUATION SYSTEM.
REF P IS MILPERSMAN 1616-050, ENLISTED PERFORMANCE (E-5 AND BELOW).
REF Q IS MILPERSMAN 1320-308, PERMANENT CHANGE OF STATION (PCS) TRANSFER
ORDER EXECUTION.
REF R IS POLICY DECISION MEMORANDUM 003-06, ASSIGNMENT INCENTIVE PAY
PROGRAM.
REF S IS POLICY DECISION MEMORANDUM 002-21, SEA DUTY INCENTIVE PAY PROGRAM.
REF T IS OPNAVINST 1160.6C, SPECIAL DUTY ASSIGNMENT PAY PROGRAM.
REF U IS OPNAVINST 1160.8B, SELECTIVE REENLISTMENT BONUS PROGRAM.
REF V IS OPNAVINST 1520.23C, GRADUATE EDUCATION.
REF W IS MILPERSMAN 1160-040, EXTENSION OF ENLISTMENTS.
REF X IS SECNAVINST 1420.2B, FROCKING OF COMMISSIONED OFFICERS.
REF Y IS BUPERSINST 1430.16G, ADVANCEMENT MANUAL FOR ENLISTED PERSONNEL OF
THE U.S. NAVY AND U.S. NAVY RESERVE.
REF Z IS SECNAVINST 1420.3, DEPARTMENT OF THE NAVY COMMISSIONED OFFICER
PROMOTION PROGRAM.
REF AA IS SECNAVINST 1412.6M, PROMOTION OF OFFICERS TO THE GRADE OF
LIEUTENANT (JUNIOR GRADE) IN THE NAVY AND TO THE GRADE OF FIRST LIEUTENANT IN
THE MARINE CORPS.
RMKS/1. Purpose. This NAVADMIN provides guidance to Commanders regarding
Navy service members who fail to obey a lawful order by refusing the COVID-19
vaccine directed in references (a) through (c).
2. Policy. In order to ensure a fully vaccinated force, U.S. Navy policy is
to process for separation all Navy service members who refuse the lawful
order to receive the COVID-19 vaccination and do not have an approved
exemption. Specific administrative actions are directed herein, however,
additional administrative actions and any punitive actions based solely on
vaccine refusal continue to be withheld.
2.a. The least favorable characterization of service for Navy service
members refusing the vaccine, without extenuating circumstances, will be
GENERAL (under honorable conditions). A general discharge will, at the
discretion of the Department of Veterans Affairs (VA), result in the loss of
eligibility for some VA benefits such as the GI Bill, to include the transfer
of GI Bill benefits to dependents.
2.b. Navy service members with approved or pending COVID-19 vaccination
exemption requests shall not be processed for separation or be subject to the
other administrative actions described in this NAVADMIN due solely to their
lack of COVID-19 vaccination. However, in line with reference (d), Navy
service members who are not vaccinated, regardless of exemption status, may
be temporarily reassigned with concurrence of the first flag officer in the
administrative chain of command based on operational readiness and mission
requirements. Where applicable, the first flag officer in the operational
chain of command should be notified regarding temporary reassignments.
2.c. Navy service members whose COVID-19 vaccination exemption request is
denied are required to receive the COVID-19 vaccine as directed by the
exemption adjudicating authority or commence vaccination within 5 days of
being notified of the denial, if the exemption adjudicating authority does
not specify. Navy service members who refuse the COVID-19 vaccine after
expiration of the specified time to commence vaccination, will be processed
for separation and be subject to the other administrative actions described
in this NAVADMIN and reference (d).
2.d. Navy service members who initiate vaccination such that they cannot
meet the deadline described in references (b) and (c) or the applicable
deadline established by receipt of an exemption denial, should notify their
chain of command as soon as possible. The Navy service members command must
expeditiously report the case to the COVID Consolidated Disposition Authority
via *pers-834@navy.mil* for officers and
*pers832covidvaxadseps@us.navy.mil* for enlisted, in order to expedite
determination regarding whether to initiate or suspend administrative
separation and the other actions directed by this NAVADMIN.
2.e. Notwithstanding the policy to separate Navy service members refusing
the vaccine, each and every Navy service member shall be treated with dignity
and respect at all times throughout the execution of the policies described
herein.
3. Definitions.
3.a. Navy Service Members. Active-duty service members and service members
in the Selected Reserve only. Service members in the Individual Ready
Reserve and U.S. Naval Academy (USNA) and Naval Reserve Officers Training
Corps (ROTC) midshipmen remain subject to the vaccine mandates in references
(a) through (c), but will be adjudicated per their governing instructions.
3.b. Active-Duty Navy Service Members. Active-duty Navy service members
include members of the Active Component and members of the Reserve Component
on active duty in a full time support (FTS) status (also known as Training
and Administration of the Reserve (TAR)).
3.c. Refusing the Vaccine. A Navy service member refusing the vaccine is
one who has: (1) received a lawful order to be fully vaccinated against
COVID-19, (2) is not or will not be fully vaccinated on the date required by
the order, and (3) does not have a pending or approved exemption request per
references (e) through (h).
3.d. Fully Vaccinated. Service members are considered fully vaccinated two
weeks after completing an approved COVID-19 vaccination series per reference
(c).
3.e. Commanders. Commanders, Commanding Officers and Officers-in-Charge of
naval units or organizations.
4. General Guidance.
4.a. Continue to hold submission of administrative separation (ADSEP) cases
or convening administrative separation boards until directed by the CCDA.
4.a.(1). Final directions for submission of misconduct and ADSEP requests
based solely on vaccine refusal are expected to be promulgated during the
first week of December 2021. In preparation for submission, Commanders shall
prepare Reports of Misconduct, applicable NAVPERS 1070/613s and any other
supporting documents. Templates and additional information can be found at
*https://www.mynavyhr.navy.mil/Career-Management/Personnel-Conduct-
Sep/Officer-Performance-Separation/* and
*https://www.mynavyhr.navy.mil/Career-Management/Personnel-Conduct-
Sep/Enlisted-Separations/*. A NAVPERS 1070/613 specifically written for
Navy service members who refuse the COVID-19 vaccine is located at
*https://www.mnp.navy.mil/group/navy-covid-19-reporting*
for Commanders use.
4.a.(2). Entry Level Separation (ELS). Commanders will continue separation
of Navy enlisted service members refusing the vaccine who meet ELS criteria
per MILPERSMAN (MPM) 1910-154. In accordance with MPM 1910-600, forward
completed administrative separation records to PERS-832 via email at
*pers832covidvaxadseps@us.navy.mil* for filing in members official
military personnel file (OMPF).
4.b. Commanders will notify those Navy service members refusing the vaccine
who are executing funded or no-cost TAD orders for training, or any other
official purpose, to halt their assigned activity and return to their command
within five working days.
4.c. Generally, Navy service members refusing the vaccine will continue in
their assigned duties pending adjudication of separation processing and other
applicable administrative actions described within this NAVADMIN. Commanders
shall ensure appropriate risk mitigations remain in place to prevent the
spread of COVID-19. If, in the Commanders judgment, a local reassignment
becomes necessary, Commanders should coordinate disposition and timing with
their Immediate Superior in Command (ISIC).
5. Administrative Disposition Guidance.
5.a. The data reporting required by NAVADMIN 249/21, reference (k), meets
the requirements of MPM 1611-010 (officers) and MPM 1616-040 (enlisted) to
inform PERS-834 (officers) and PERS-832 (enlisted) of incidents that could
result in adverse action for officers and enlisted (E-6 through E-
9). However, if a Navy service member refusing the vaccine (including those
E5 and below) has a pending transfer, promotion or advancement: submit the
additional information, as described below, as soon as feasible to ensure
appropriate preemptive action is taken. Include *COVID-19 Vaccine Refusal*
in the subject line of the email.
5.a.(1). Officers. Email *pers-834@navy.mil* with members name, rank,
brief description of the offense (e.g. COVID-19 Vaccine Refusal), pending
promotion/advancement status, and the commands POC (Name, rank/rate, email
and phone number).
5.a.(2). Enlisted. Email *pers832covidvaxadseps@us.navy.mil* with
members name, rank and rate, brief description of the offense (e.g. COVID-19
Vaccine Refusal), pending promotion/advancement status, and the commands POC
(Name, rank/rate, email and phone number).
6. Documentation in Fitness Reports and Enlisted Evaluations.
6.a. Officers.
6.a.(1). In accordance with reference (d), within 30 days of a Navy service
member refusing the vaccine, the reporting senior shall issue an adverse
special Fitness Report (FITREP) per MPM 1610-015 and BUPERSINST
1610.10E. These reports should be submitted no earlier than the *to* date
described below.
6.a.(2). The adverse special FITREP will document failure of the member to
comply with Individual Medical Readiness responsibilities as outlined
below. The adverse special FITREP shall document other facts as appropriate,
including any additional misconduct associated with vaccine refusal, as
described in BUPERSINST 1610.10E. The *to* date in block 15 of this adverse
special FITREP will be as follows: 2021Nov28 (active duty service members and
FTS/TAR), 2021Dec28 (SELRES). For Navy service members who requested an
exemption which was denied and subsequently refuse the vaccine, the *to* date
in block 15 shall be 14 days after expiration of the specified time to
commence vaccination as discussed in para 2.c. or the applicable date
specified in the previous sentence, whichever is later.
6.a.(3). The adverse special FITREP will contain no greater than a 2.0 in
block 35 (Military Bearing/Character) and no greater than a 2.0 in block 38
(Leadership). Block 42 (Promotion Recommendation) will be marked as
*Significant Problems*. The following sentence must be the opening statement
in block 41: *Member failed to maintain deployability or individual readiness
standards by refusing the order to receive the COVID-19 vaccine.* A report
without these marks and this statement will be rejected and returned for
correction.
6.b. Enlisted members.
6.b.(1). In accordance with reference (d), within 30 days of a Navy service
member refusing the vaccine, the reporting senior shall issue an adverse
special evaluation per MPM 1610-015 and BUPERSINST 1610.10E. The adverse
special evaluation will document failure of the member to comply with
Individual Medical Readiness responsibilities as outlined below. The adverse
special evaluation shall document other facts as appropriate, including any
additional misconduct associated with vaccine refusal, as described in
BUPERSINST 1610.10E. The *to* date in block 15 of this adverse special
evaluation will be as follows: 2021Nov28 (active duty service members and
FTS/TAR), 2021Dec28 (SELRES). For Navy service members who requested an
exemption which was denied and subsequently refuse the vaccine, the *to* date
in block 15 shall be 14 days after expiration of the specified time to
commence vaccination as discussed in para 2.c. or the applicable date
specified in the previous sentence, whichever is later. These reports should
be submitted no earlier than the *to* date described above.
6.b.(2). E-1 to E-6 Evaluations. The adverse special evaluation will
contain no greater than a 2.0 in block 36 (Military Bearing/Character) and no
greater than a 2.0 in block 39 (Leadership). Block 45 (Promotion
Recommendation) will be marked as *Significant Problems* and block 47
(Retention) will be marked as *Not Recommended*. The following sentence must
be the opening statement in block 43: *Member failed to maintain
deployability or individual readiness standards by refusing the order to
receive the COVID-19 vaccine.* A report without these marks and this
statement will be rejected and returned for correction.
6.b.(3). E-7 to E-9 Evaluations. The adverse special evaluation will
contain no greater than a 2.0 in block 37 (Character) and no greater than a
2.0 in block 33 (Deckplate Leadership). Block 42 (Promotion Recommendation)
will be marked as *Significant Problems*. The following sentence must be the
opening statement in block 41: *Member failed to maintain deployability or
individual readiness standards by refusing the order to receive the COVID-19
vaccine.* A report without these marks and this statement will be rejected
and returned for correction.
7. Permanent Change of Station (PCS) orders execution guidance. Navy service
members refusing the vaccine who are under PCS orders will adhere to the
following guidance.
7.a. Navy service members and dependents who have not yet initiated PCS
travel shall not execute orders. Commands are directed to contact Navy
Personnel Command (NPC) for follow-on guidance per MPM 1611-010, MPM 1616-
040, and MPM 1616-050. NPC is standing by to address each specific case and
will authorize entitlements based on current location and situation.
7.b. For Navy service members and/or dependents who have already initiated
PCS travel, detaching and gaining commands shall make every effort to contact
those service members to advise them of the requirements of this
message. The service member should contact their detailer directly and each
case will be evaluated by NPC on a case by case basis. Commands are directed
to contact NPC for follow-on guidance per MPM 1611-010, MPM 1616-040 and MPM
1616-050. Per MPM 1320-308, members traveling under orders are considered to
be attached to the gaining command.
7.c. Commanders should contact their ISIC to discuss impacts on manning
resulting from this PCS orders execution guidance. ISICs should discuss
manning impacts with their respective Type Commander N1, officer and enlisted
community detailers, and placement coordinator (PERS 4013).
7.d. For new accession Navy service members in the accession training
pipeline, (e.g. Recruit Training Command and A and C Schools) who refuse the
vaccine and do not have a pending exemption request, Commanders will
immediately interrupt their training, place them in an Interrupted
Instruction (II) status and hold them at current activity.
7.e. For new accession Navy service members in the accession training
pipeline, (e.g. Recruit Training Command and A and C Schools) who have a
pending exemption request, Commanders will continue their accession level
training (including transfer between schools), but will not transfer them to
their ultimate assignment until adjudication of their exemption
request. Once complete with all available accession level training,
Commanders will place the service member in an Interrupted Instruction (II)
status and hold them at current activity until the exemption request is
adjudicated.
8. Bonuses, Special Pays and Incentive Pays. Navy service members refusing
the vaccine may not enter into any new agreements for bonuses, special pays,
or incentive pays and any unearned portion of current bonuses, special pays
and incentive pays will be recouped in accordance with references (r) through
(u). Examples include, but are not limited to, the following: career
retention bonuses, enlistment bonuses and incentive pays (such as flight
pay). Bonuses, special pays and incentive pays become unearned when a Navy
service member refusing the vaccine is no longer performing duties for which
they are receiving such a bonus, special pay, or incentive pay (i.e. removed
from assignment).
8.a. Bonuses, special pays and incentive pays become unearned as soon as one
of the following criteria is met:
8.a.(1). Removed from the assignment.
8.a.(2). Associated NEC/AQD/warfare qualification is removed.
8.a.(3). Separated.
8.b. Actions required by Commanders with regard to special and incentive
pays.
8.b.(1). For assignment or incentive pays, if a Navy service member is
removed from an assignment, the Commander shall notify the office responsible
for any special and incentive pays of the change of assignment. For
Assignment Incentive Pay (AIP), notify PERS-40DD via email at
*mill_aip@navy.mil*. For Special Duty Incentive Pay notify PERS-40DD via
email at *mill_sdip@navy.mil*. For Special Duty Assignment Pay, notify
the servicing Personnel Support Detachment/Transaction Support Center and the
rating detailer.
8.b.(2). For bonuses, if a Navy service member is removed from an assignment
and is no longer eligible for a bonus, notify the office responsible for that
bonus. For Selective Reenlistment Bonuses, notify OPNAV (N130) via email at
*nxag_n130d@navy.mil*.
8.b.(3). Upon removal from an assignment, Commanders will ensure the NAVPERS
1070/613 specifically written for Navy service members refusing the vaccine
is completed and saved in the service members electronic service
record. This NAVPERs 1070/613 can be found at
*https://www.mnp.navy.mil/group/navy-covid-19-reporting*.
9. Education. Navy service members refusing the vaccine are not eligible to
continue Navy education opportunities and those who fail to complete a
service obligation incurred for participating in Navy funded full-time, part-
time, or off-duty education programs per OPNAVINST 1520.23C will be required
to reimburse the cost of the education received, prorated for the obligated
time served.
9.a. Institutional Education. Navy service members refusing the vaccine who
incurred a service obligation for an education benefit (e.g. USNA, ROTC,
Naval Postgraduate School, Health Professional Scholarship Program or in-
residence Professional Military Education), will have any unearned portion of
that education benefit recouped if separated before completing the service
obligation. Navy service members refusing the vaccine (as defined in para.
3) currently enrolled in such an education program will be dis-enrolled from
their program as soon as feasible and held at their institution or command
pending administrative separation. Note: Current USNA and ROTC Midshipmen
will be adjudicated by governing instructions as discussed in para. 3.a.
9.b. Tuition Assistance (TA). Navy service members refusing the vaccine are
ineligible to receive TA. Commanders must withdraw command approval for any
TA courses not yet convened. Commanders will direct withdrawal from TA
courses which have convened and require proof of withdrawal. Navy service
members will be responsible for reimbursing the Navy for the amount listed on
the TA Authorization Voucher. Officers administratively separated prior to
completing the statutory two year obligation for receipt of TA will incur a
debt.
9.c. SkillBridge. Navy service members refusing the vaccine are not
eligible to participate in the SkillBridge program. Commanders will
immediately remove SkillBridge approval and recall Navy service members
refusing the vaccine as indicated below.
9.c.(1). Navy service members assigned to commands in the Continental United
States (CONUS) will return to their permanent duty station at their own cost
within five days of recall order. If the command is deployed or underway,
Sailors will report to the Transient Personnel Detachment in their home port.
9.c.(2). Navy service members assigned to commands outside the Continental
United States (OCONUS) will report to the nearest CONUS Transient Personnel
Detachment at their own cost as directed by their command within five days of
recall order.
9.d. Navy Credentialing Opportunities Online (COOL). Navy service members
refusing the vaccine are not eligible for Navy COOL funding for examinations
or related credentialing fees. Commanders will withdraw approval of
unexecuted vouchers and withhold future voucher approval for Navy service
members refusing the vaccine.
10. Navy Training. In cases where there is a clearly defined service
obligation that is not met, the cost of Navy training will be recouped,
prorated to the obligated time served. Additionally, each case of a Navy
service member refusing the vaccine will be evaluated for recoupment of
training costs based on individual circumstances such as total cost, service
obligation, and the Navy’s realized return on investment for training
received.
11. Reenlistments and Extensions. Navy service members refusing the vaccine
are not eligible for re-enlistment, and may not extend their enlistment. If
a Navy service member refusing the vaccine has entered into an extension
agreement that is not yet operative (has not yet taken effect), Commanders
must cancel these agreements to extend enlistment. The inoperative extension
can be cancelled by the personnel office by completing the cancellation
section of NAVPERS 1070/621 or NAVPERS 1070/622 and processing the
corresponding NSIPS event per MPM 1160-040.
12. Promotion and Advancement. Navy service members refusing the vaccine
who are in a frocked status should be defrocked as soon as feasible (officers
per SECNAVINST 1420.2B, enlisted per BUPERSINST 1430.16G). Spot promoted
officers refusing the vaccine should be replaced as soon as feasible. Once
removed from the applicable spot promote billet, the command should contact
the members detailer and PERS-806 to remove the spot promotion.
12.a. Officer Promotion Delay. Commanders shall delay the promotion of any
officer refusing the vaccine and shall submit a NAVPERS 1070/13 to
*npc_promotionwithholds.fct@navy.mil* stating the members promotion is
delayed due to COVID-19 vaccine refusal (per SECNAVINST 1420.3 or SECNAVINST
1412.6M). Delays shall be based upon pending administrative action and
physical qualification. Navy Personnel Command will make formal written
notice to the officer following notification from the Commander. A NAVPERS
1070/613 specifically written for Navy service members who refuse
the COVID-19 vaccine is located at
*https://www.mnp.navy.mil/group/navy-covid-19-reporting* for Commanders use.
12.b. Enlisted Advancement Withhold. Commanders shall withhold the
advancements of any enlisted member refusing the vaccine, to include
preventing automatic Time-In-Rate advancements for E-2/E-3 and advancement
for any Sailors in a frocked status for paygrades E-3 through E-9.
12.c. Enlisted Advancement Withdrawal. The date of the special adverse
evaluation from paragraph 6.b. above constitutes a permanent withdrawal of
advancement recommendation effective as of the date of the reporting seniors
signature. An example NAVPERS 1070/13 for enlisted members pending
advancement is available in BUPERSINST 1430.16G, Chapter 7.
13. Community sponsor flag officers are authorized to make determinations
within their communities regarding removal of warfare qualifications,
additional qualification designations (AQD), Navy Enlisted Classifications
(NEC), or sub-specialties for Navy service members refusing the vaccine. Any
decision to remove warfare qualifications, AQDs, NECs, or sub-specialties
shall be consistent with current community policies and normal practices for
Navy service members who do not maintain deployability or individual
readiness through their own actions. These decisions, when based solely on
refusing the vaccine, must be administrative in nature rather than punitive.
14. If in doubt as to how to adjudicate issues related to a Navy service
member refusing the vaccine, Commanders should seek guidance from their chain
of command, their staff judge advocate, and/or the CCDA before acting. In
all cases, Commanders are accountable to ensure the health and safety of
their command while treating every Navy service member with dignity and
respect.
15. Points of contact.
My Navy Career Center: 833-330-6622, *askmncc@navy.mil*.
Retirements and Separations (PERS-8): *mill_pers-8@navy.mil*,
(901) 874-3264.
Bonus Programs, Special and Incentive Pays (OPNAV N130D):
*nxag_n130d@navy.mil*.
Enlisted Force Plans and Policy (OPNAV N132): *nxag_n132c@navy.mil*.
OPNAV POC: CAPT Jason Grizzle, *altn_n1_navy_scr.fct@navy.mil*.
16. Released by VADM John B. Nowell, Jr, COVID Consolidated Disposition
Authority.
BT
#0001
NNNN
UNCLASSIFIED//